Amgen Stock News

Healthcare and travel are both durable targets for consumer spending over the long term. Amgen delivered excellent financial figures in the recent quarter, driven by new and flagship products.

Results Illustrate Depth and Diversity of Amgen's Targeted Therapies Across Tumor Types THOUSAND OAKS, Calif. , Sept. 13, 2024 /PRNewswire/ -- Amgen (NASDAQ: AMGN) today announced the presentation of new data across its broad oncology pipeline and portfolio at the European Society for Medical Oncology (ESMO) Congress 2024, taking place Sept.

Eli Lilly and Novo Nordisk have been top stocks for investors who are bullish on the weight loss market. However, fellow biotech Amgen could possess more upside given its more modest valuation.

DeLLphi-303 Study Results Show Potential for IMDELLTRA in Combination with a PD-L1 Inhibitor as First-Line Maintenance Therapy in ES-SCLC DeLLphi-301 Long-Term Follow-up Data Demonstrate Sustained Safety and Efficacy for IMDELLTRA THOUSAND OAKS, Calif. , Sept. 9, 2024 /PRNewswire/ -- Amgen (NASDAQ:AMGN) today announced the presentation of new data showcasing IMDELLTRATM (tarlatamab-dlle), a fir...

Buy Low, Sell High, Get Paid To Wait: Our simple investment philosophy focuses on purchasing assets at a discount to their intrinsic value. Key factors for maximizing profit include industry growth, management quality, and buying at a discount to value. Dividends from companies with good management and growing cash flows help determine value relative to historical norms.

Biotech investing is a thrill-a-minute ride. Biotech stocks can take investors soaring to new heights and fabulous wealth opportunities or send them into the pits of despair.

"The Dow® [adds a stock] if the company has an excellent reputation, demonstrates sustained growth, and is of interest to a large number of investors

Amgen Inc. (NASDAQ:AMGN ) Wells Fargo 2024 Healthcare Conference Call September 5, 2024 9:30 AM ET Company Participants Justin Claeys - Vice President of Investor Relations Jay Bradner - Executive Vice President, Research and Development & Chief Scientific Officer Peter Griffith - Executive Vice President & Chief Financial Officer Conference Call Participants Mohit Bansal - Wells Fargo Mohit Ba...